US2012101161A1PendingUtilityA1
Fatty acid analogues for the treatment of inflammatory and autoimmune disorders
Est. expiryNov 28, 2020(expired)· nominal 20-yr term from priority
A61P 9/14A61P 7/04A61P 5/38A61P 9/10A61P 37/00A61P 3/10A61P 5/14A61P 37/08A61P 7/00A61P 37/02A61P 37/06A61P 9/04A61P 43/00A61P 29/00A61P 31/10A61P 25/02A61P 25/28A61P 31/04A61P 25/00A61P 31/12A61P 35/00A61K 31/19A61K 31/20A61P 21/04A61P 19/10A61P 17/06A61P 13/12A61P 1/04A61K 31/22A61P 19/02A61P 17/00A61P 21/00A61P 1/02
42
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The present invention relates to fatty acid analogues of the general formula R 1 -[x i -CH 2 ] n —COOR 2 and in particular to a method of treating inflammatory disorder selected from the group consisting of rheumatoid arthritis, systemic vasculitis, systemic lupus erythematosus, systemic sclerosis, dermatomyositis, and polymyositis; comprising administering to a mammal in need thereof, an effective amount of tetradecylthioaceticacid or tetradecylselenoacetic acid; or a pharmaceutically acceptable salt thereof.
Claims
exact text as granted — not AI-modified1 . A method of treating inflammation comprising administering to a mammal in need thereof, an effective amount of tetradecylthioacetic acid or tetradecylselenoacetic acid; or a pharmaceutically acceptable salt thereof, under conditions that said inflammation is reduced.
2 . The method of claim 1 , wherein said administration is oral.
3 . The method of claim 1 , wherein said administration is topical.
4 . The method of claim 1 , wherein said administration is parenteral.Join the waitlist — get patent alerts
Track US2012101161A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.